• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.

作者信息

Lindeboom J E, Kingma J H, Crijns H J, Dunselman P H

机构信息

Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands.

出版信息

Am J Cardiol. 2000 Apr 15;85(8):1031-3. doi: 10.1016/s0002-9149(99)00927-3.

DOI:10.1016/s0002-9149(99)00927-3
PMID:10760352
Abstract
摘要

相似文献

1
Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.静脉注射多非利特快速终止心房颤动和心房扑动的疗效及安全性。
Am J Cardiol. 2000 Apr 15;85(8):1031-3. doi: 10.1016/s0002-9149(99)00927-3.
2
Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.静脉注射多非利特在急性终止心房颤动和心房扑动中的疗效与安全性：一项多中心、随机、双盲、安慰剂对照试验。丹麦多非利特治疗心房颤动和心房扑动研究组
Am Heart J. 1999 Jun;137(6):1062-9. doi: 10.1016/s0002-8703(99)70363-7.
3
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators.静脉注射多非利特，一种III类抗心律失常药物，用于终止持续性心房颤动或心房扑动。静脉注射多非利特研究人员。
J Am Coll Cardiol. 1997 Feb;29(2):385-90. doi: 10.1016/s0735-1097(96)00506-2.
4
Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.静脉注射多非利特与胺碘酮用于急性终止心房颤动和心房扑动的比较。一项多中心、随机、双盲、安慰剂对照研究。
Eur Heart J. 2000 Aug;21(15):1265-73. doi: 10.1053/euhj.1999.2039.
5
Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study.口服多非利特在慢性心房颤动或心房扑动患者转复并维持窦性心律中的疗效与安全性：多非利特症状性心房颤动研究（SAFIRE-D）
Circulation. 2000 Nov 7;102(19):2385-90. doi: 10.1161/01.cir.102.19.2385.
6
Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter.新型选择性Ⅲ类抗心律失常药物多非利特对阵发性心房颤动或心房扑动的疗效及安全性
Am J Cardiol. 1992 Feb 1;69(4):417-9. doi: 10.1016/0002-9149(92)90247-v.
7
Chemical cardioversion of atrial fibrillation with intravenous dofetilide.静脉注射多非利特用于心房颤动的化学复律。
Int J Cardiol. 1995 Apr;49(2):159-66. doi: 10.1016/0167-5273(95)02284-4.
8
[Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter].口服多非利特在慢性心房颤动或心房扑动患者转复并维持窦性心律中的疗效与安全性
Ital Heart J Suppl. 2001 Mar;2(3):322-3.
9
Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group.新型III类抗心律失常药物多非利特在冠状动脉搭桥术后急性终止心房颤动或心房扑动中的疗效和安全性。多非利特冠状动脉搭桥术后研究组。
Int J Cardiol. 1997 Jan 31;58(2):135-40. doi: 10.1016/s0167-5273(96)02856-2.
10
Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.静脉注射伊布利特快速终止心房颤动和心房扑动的疗效：一项剂量反应研究。
J Am Coll Cardiol. 1996 Jul;28(1):130-6. doi: 10.1016/0735-1097(96)00121-0.

引用本文的文献

1
Mechanisms of Chemical Atrial Defibrillation by Flecainide and Ibutilide.氟卡尼和伊布利特的化学性心房除颤机制
JACC Clin Electrophysiol. 2024 Dec;10(12):2658-2673. doi: 10.1016/j.jacep.2024.08.009. Epub 2024 Oct 9.
2
External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.体外电复律和药物复律治疗心房颤动、心房扑动或房性心动过速的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD013255. doi: 10.1002/14651858.CD013255.pub2.
3
Inhibition of K2 and K11.1 Channels in Pigs With Left Ventricular Dysfunction.
抑制左心室功能不全猪的K2和K11.1通道。
Front Pharmacol. 2020 May 6;11:556. doi: 10.3389/fphar.2020.00556. eCollection 2020.
4
Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses.多非利特与雷诺嗪联合应用于马急性诱导心房颤动模型的抗心律失常作用。
J Cardiovasc Pharmacol. 2018 Jan;71(1):26-35. doi: 10.1097/FJC.0000000000000541.
5
Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.抗心律失常药物治疗心房颤动
J Atr Fibrillation. 2013 Jun 30;6(1):864. doi: 10.4022/jafib.864. eCollection 2013 Jun-Jul.
6
Pharmacological cardioversion of atrial fibrillation: current management and treatment options.心房颤动的药物复律：当前的管理与治疗选择
Drugs. 2004;64(24):2741-62. doi: 10.2165/00003495-200464240-00003.
7
Advances in the acute pharmacologic management of cardiac arrhythmias.心律失常急性药物治疗的进展
Curr Cardiol Rep. 2003 Sep;5(5):387-94. doi: 10.1007/s11886-003-0096-y.
8
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation.抗心律失常药物促进心房颤动患者窦性心律有效性的随机对照试验的荟萃分析。
Heart. 2002 Jun;87(6):535-43. doi: 10.1136/heart.87.6.535.
9
Dofetilide: a review of its use in atrial fibrillation and atrial flutter.多非利特：其在心房颤动和心房扑动中应用的综述
Drugs. 1999 Dec;58(6):1043-59. doi: 10.2165/00003495-199958060-00007.